Schedule 13D ownership disclosure

Nascent Biotech Inc.

Security class unavailable · CUSIP: 63108Q101

Event date: 2023-04-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001477932-23-002546
Form type
SC 13D
Filer
Burke Robert David
CIK
CIK 1973753
Filed
Apr 14, 2023
Reporting period
Apr 14, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub